跳至主要内容
临床试验/NCT01628731
NCT01628731已完成3 期

Phase III Study of Furosemide Continuous Infusion Versus Ethacrynic Acid Continuous Infusion in Children Undergoing Cardiac Surgery: Randomized Double Blind Controlled Clinical Trial

Bambino Gesù Hospital and Research Institute1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
74
试验地点
1
主要终点
Mean total urine output production in the first post-operative day

研究概览

简要总结

This study aims to verify if ethacrynic acid continuous infusion is superior to furosemide continuous infusion in total urine output production during the first 24 post operative hours.

详细描述

Diuretic therapy in children after open heart surgery is widely administered, though no evidence currently supports if an ideal drug or an ideal dosage can be recommended. Loop diuretics are the most effective drugs in terms of urine output production but may cause some collateral effects such as metabolic alkalosis, hypovolemia, hypokalemia, ototoxicity. Furthermore, some reports showed that loop diuretics usage can be associated with an increased risk of renal dysfunction and mortality. However, their use in children with signs of fluid overload, pulmonary edema or oliguria is mandatory and widely practiced.

Furosemide and ethacrynic acid are often prescribed and administered without any specific indication, basing on clinicians preferences.

No study so far, explored the hypothesis of which of these drugs is the most effective in terms of urine output production and safe in terms of renal function.

This study aims to verify if ethacrynic acid continuous infusion is superior to furosemide continuous infusion in total urine output production during the first 24 post operative hours.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children with congenital heart disease undergoing cardiac surgery
  • intraoperative aortic cross clamp over 90 minutes or interventional catheterization procedures with post-operative inotrope score over 20
  • sign of fluid retention after surgical procedures

排除标准

  • Preoperative renal dysfunction
  • Preoperative administration of more than 4mg/kg/die loop diuretics
  • Need for renal replacement therapy at ICU admission
  • Need for ECMO at ICU admission

研究组 & 干预措施

furosemide

Active Comparator

furosemide, 0.2 mg/kg/h up to 0.8 mg/kg/h for 72 hours

干预措施: furosemide (Drug)

ethacryinic acid

Active Comparator

ethacrynic acid, 0.2 mg/kg/h up to 0.8 mg/kg/h for 72 hours

干预措施: ethacrynic acid (Drug)

结局指标

主要结局

Mean total urine output production in the first post-operative day

时间窗: first 24 hours after Intensive Care Unit admission

Verification of the superiority of ethacrynic acid compared with furosemide in improving patients' total urine output by at least 1 ml/kg/h in the first 24 post-operative hours

次要结局

  • Mean creatinine and NGAL values(first 72 hours after Intensive Care Unit admission)

研究者

发起方
Bambino Gesù Hospital and Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zaccaria Ricci

Medical Doctor, Research Fellow

Bambino Gesù Hospital and Research Institute

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
不适用
Comparison between high and low doses and between two different intravenous administration modalities in patients with advanced heart failure.Advanced Heart FailureMedDRA version: 14.1Level: LLTClassification code 10024106Term: Left heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: HLGTClassification code 10019280Term: Heart failuresSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: LLTClassification code 10019285Term: Heart failure, unspecifiedSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: LLTClassification code 10019284Term: Heart failure, congestiveSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: HLTClassification code 10019283Term: Heart failure signs and symptomsSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: LLTClassification code 10070760Term: Acute bi-ventricular heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: LLTClassification code 10010684Term: Congestive heart failureSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2013-000866-12-ITA. O. Città della Salute
已完成
2 期
Sub-Q Versus IV Furosemide in Acute Heart FailureCongestive Heart Failure
NCT02579057Johns Hopkins University40
已完成
3 期
BAY14-2222 Continuous Infusion in SurgeriesHemophilia
NCT00606060Bayer15
已完成
3 期
Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)Heart Failure,Congestive
NCT04628325University of Palermo136
已完成
3 期
Furosemide vs. Placebo for Severe Antepartum HypertensionHypertension in PregnancyPregnancy ComplicationsHypertension, Pregnancy-InducedPre-Eclampsia
NCT04615624Melanie Maykin, MD65